Oculentis is one of the few remaining independent IOL manufacturers having their own Research and Development Department and one of the most modern manufacturing plants for intraocular lenses.
The LENSAR Laser System offers cataract surgeons precision and accuracy, while optimizing visual outcomes. LensAR is a leading global leader in next generation femtosecond laser technology for refractive cataract surgery.
SCHWIND eye-tech-solutions is the specialist for refractive and therapeutic corneal surgery. The company develops, produces and markets a comprehensive product portfolio for the treatment of ametropia and corneal diseases. In more than fifty-seven years of steady growth and development, the owner operated family enterprise has advanced from diagnostics technology supplier for ophthalmologic practices to technological leader in eye laser systems.
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.”
1stQ® offers top-of-the-line technology for improved quality of life following cataract surgery. Unique intraocular lenses provide individually optimized visual capability for all patients.
Medicem is an integrated group of biomedical companies focused on researching, developing, and commercializing medical devices.
MANI Inc. is a Japanese multinational medical devices and dental instruments manufacturer founded in 1956. MANI has contributed to the world healthcare industry since its inception in 1956 and it sells over 10,000 kinds of surgical needles and 3,000 kinds of dental instruments in more than 120 countries worldwide.
ASICO® Ophthalmic instruments provides the latest in Ophthalmic surgical instrument technology for precision treatments for cataract, cornea, glaucoma, refractive and retina. All ASICO ophthalmic surgical instruments are unconditionally guaranteed for life against manufacturing defects in material and workmanship when used for their intended surgical purpose and cared for in accordance with recommended procedures.
Founded in 2013, ISP Surgical is a unique surgical devices distribution company. ISP Surgical identifies innovative technologies and surgical solutions from Asian, European, American manufacturers, and make them available to leading Ophthalmologists primarily in South East Asia.
Sensimed AG, a Swiss company, has developed a unique non-invasive soft contact lens-based solution, the SENSIMED Triggerfish®, with the aim of revolutionizing glaucoma management by providing an automated recording of continuous ocular dimensional change over 24 hours.
Aptissen SA is a company specialized in the research & development, manufacturing and commercialization of biopolymer-based medical devices. Aptissen SA stands for Advanced Polymer for TISSue ENgineering, which clearly gives a hint about the company’s skills.
Mediphacos is a world class Brazilian company with an international presence in more than 60 countries on 5 continents. Mediphacos has achieved a leading position in the market by investing heavily in research, development and innovation, by constantly updating its technology and constantly remaining focused on the needs of ophthalmologists.
Making eye surgery safer, simpler and more effective: This principle is Medicel’s core ethic from conceptual design to product development then into manufacturing and assembly.
Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Today, more than 100,000 eyes around the world have been treated with Avedro’s KXL® System for Accelerated Cross-Linking.
Peshke Trade’s passion for helping patients with corneal diseases, providing the best equipment to exercise cross-linking procedures drives our company to collaborate with the best opinionated leaders and medical professionals worldwide.
MED-LOGICS, Inc. is focused on improving the results of LASIK, donor cornea procedures, and cataract surgery for patients around the world.
Aeon Astron B.V. is dedicated to global sales and marketing for high value added and novel medical devices, as well as research and development of biomaterial and regenerative medicine for ophthalmological applications. These devices include ologen® Collagen Matrix, BioCornea, and BioLens, which are designed not only for eye tissue repair and vision improvement but also for improving the quality of life.
The company manufactures and markets a full range of ultrasound and laser products designed for ophthalmology. Being a pioneer in the development of medical technologies, Quantel Medical has become the leader in both ocular ultrasound and laser photocoagulation.
Clarity Medical Systems develops, manufacture, and market integrated optical systems and services designed to enhance clinicians’ ability to diagnose, manage, and treat eye disorders.
i-Optics has a long term goal: that 15 years from now, there should be no reason to suffer from vision loss because of inadequate eye diagnoses or therapeutic solutions. i-Optics wants to contribute to this goal by offering smarter eye diagnosis tools that cost less, perform better, and are developed with the healthcare consumer in mind.
The Optimed’s CAPTIV8 patient communication service offers truly amazing 3D animations delivered on a patient education platform like no other
PRN is a leading producer of food-based supplements, often referred to as nutritional supplements or nutriceuticals. Omega-3 (EPA/DHA) essential fatty acids and certain vitamins are critical for good health.
TearLab is pioneering the future of tear film diagnostics to elevate patient care. Using its first of a kind point-of-care ophthalmic in vitro diagnostic platform, TearLab allows you to add data to your insights to guide the diagnosis and management of the ocular surface.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. We have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm.